Connor, Clark & Lunn Investment Management Ltd. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$8,974,000
+508.8%
160,356
+463.0%
0.06%
+555.6%
Q2 2022$1,474,000
+92.4%
28,480
+170.3%
0.01%
+125.0%
Q1 2022$766,000
-90.7%
10,537
-82.9%
0.00%
-90.7%
Q3 2021$8,281,000
-22.6%
61,732
-6.6%
0.04%
-20.4%
Q2 2021$10,704,000
+747.5%
66,112
+320.2%
0.05%
+671.4%
Q1 2021$1,263,00015,7320.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders